Search Results

β-Cyclodextrin and Hyaluronic Acid-Modified Targeted Nanodelivery System for Atherosclerosis Prevention.

• Authors : Yu J; School of Pharmacy, Xi'an Jiaotong University, Xi'an 710000. China.; Ma Y

Subjects: Hyaluronic Acid*/Hyaluronic Acid*/Hyaluronic Acid*/chemistry ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/drug therapy ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/prevention & control

• Source: ACS applied materials & interfaces [ACS Appl Mater Interfaces] 2024 Jul 10; Vol. 16 (27), pp. 35421-35437. Date of Electronic Publication: 2024 Jun 28.Publisher: American Chemical Society Country of Publication: United States NLM ID: 101504991 Publication Model: Print-Electronic Cited Medium: Internet

Record details

The natural polyphenol fisetin in atherosclerosis prevention: a mechanistic review.

• Authors : Yu W; School of Materials Science and Engineering, Hefei University of Technology, Hefei, Anhui, 230009, China.; Anhui Renovo Pharmaceutical Co., Ltd, Hefei, Anhui, 230001, China.

• Source: The Journal of pharmacy and pharmacology [J Pharm Pharmacol] 2024 May 11. Date of Electronic Publication: 2024 May 11.Publisher: Oxford University Press Country of Publication: England NLM ID: 0376363 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Immuno-modulatory role of baicalin in atherosclerosis prevention and treatment: current scenario and future directions.

• Authors : Wang L; Department of Traditional Chinese Medicine, The Eighth Affiliated Hospital of Sun Yat-Sen University, Shenzhen, China.; Huang S

Subjects: Flavonoids*/Flavonoids*/Flavonoids*/therapeutic use ; Flavonoids*/Flavonoids*/Flavonoids*/pharmacology ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/drug therapy

• Source: Frontiers in immunology [Front Immunol] 2024 Apr 18; Vol. 15, pp. 1377470. Date of Electronic Publication: 2024 Apr 18 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Efficacy and potential mechanism of atherosclerosis prevention by the active components of leech based on network pharmacology combined with animal experiments.

• Authors : Lv Q; Clinical Pharmacy Center, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.; The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, 510080, China.

• Source: Heliyon [Heliyon] 2024 Mar 08; Vol. 10 (6), pp. e27461. Date of Electronic Publication: 2024 Mar 08 (Print Publication: 2024).Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101672560 Publication Model: eCollection Cited Medium: Print ISSN: 2405-8440

Record details

A Potential Strategy for Atherosclerosis Prevention in Modernizing China - Hyperhomocysteinemia, MTHFR C677T Polymorphism and Air Pollution (PM2.5) on Atherogenesis in Chinese Adults.

• Authors : Kwok CYT; Prof KS Woo, Department of Medicine and Therapeutics, Tsang Shiu Tim Building, United College, The Chinese University of Hong Kong, Shatin NT, Hong Kong, Phone: (852) 2647 4966, Fax: (852) 2647 4966, E-mail: .; Poon YKP

Subjects: Air Pollution* ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/genetics ; Hyperhomocysteinemia*/Hyperhomocysteinemia*/Hyperhomocysteinemia*/genetics

• Source: The journal of nutrition, health & aging [J Nutr Health Aging] 2023; Vol. 27 (2), pp. 134-141.Publisher: Serdi Publisher Country of Publication: France NLM ID: 100893366 Publication Model: Print Cited Medium: Internet ISSN: 1760-4788

Record details

Atherosclerosis Prevention in Adolescents with Obesity: The Role of Moderate-Vigorous Physical Activity.

• Authors : Videira-Silva A; Pediatric University Clinic, Faculty of Medicine, Universidade de Lisboa, 1649-035 Lisbon, Portugal.; CIDEFES (Centro de Investigação em Desporto, Educação Física, Exercício e Saúde), Universidade Lusófona, 1749-024 Lisbon, Portugal.

Subjects: Carotid Intima-Media Thickness* ; Pediatric Obesity*/Pediatric Obesity*/Pediatric Obesity*/epidemiology ; Pediatric Obesity*/Pediatric Obesity*/Pediatric Obesity*/prevention & control

• Source: International journal of environmental research and public health [Int J Environ Res Public Health] 2022 Nov 23; Vol. 19 (23). Date of Electronic Publication: 2022 Nov 23.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238455 Publication Model: Electronic Cited Medium: Internet ISSN: 1660-4601

Record details

Probiotics Bring New Hope for Atherosclerosis Prevention and Treatment.

• Authors : Zhai T; Department of Laboratory Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China.; Wang P

Subjects: Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/drug therapy ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/prevention & control ; Cardiovascular Diseases*

• Source: Oxidative medicine and cellular longevity [Oxid Med Cell Longev] 2022 Sep 24; Vol. 2022, pp. 3900835. Date of Electronic Publication: 2022 Sep 24 (Print Publication: 2022).Publisher: Hindawi Pub. Corp Country of Publication: United States NLM ID: 101479826 Publication Model: eCollection Cited Medium: Internet ISSN:

Record details

Correction to: Beta‑blockers for Atherosclerosis Prevention: a Missed Opportunity?

• Authors : Vrablik M; First Faculty of Medicine, Charles University in Prague, Katerinska 32, 121 08, Prague, Czech Republic.; 3Rd Department of Internal Medicine, General Teaching Hospital, U Nemocnice 1, 128 08, Prague 2, Czech Republic.

• Source: Current atherosclerosis reports [Curr Atheroscler Rep] 2022 Mar; Vol. 24 (3), pp. 171.Publisher: Springer Country of Publication: United States NLM ID: 100897685 Publication Model: Print Cited Medium: Internet ISSN: 1534-6242

Record details

Beta-blockers for Atherosclerosis Prevention: a Missed Opportunity?

• Authors : Vrablik M; First Faculty of Medicine, Charles University in Prague, Katerinska 32, 121 08, Prague, Czech Republic.; 3rd Department of Internal Medicine, General Teaching Hospital, U Nemocnice 1, 128 08, Prague 2, Czech Republic.

Subjects: Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/drug therapy ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/prevention & control ; Heart Failure*/Heart Failure*/Heart Failure*/drug therapy

• Source: Current atherosclerosis reports [Curr Atheroscler Rep] 2022 Mar; Vol. 24 (3), pp. 161-169. Date of Electronic Publication: 2022 Feb 16.Publisher: Springer Country of Publication: United States NLM ID: 100897685 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

[Atherosclerosis prevention: new therapeutic strategies on the horizon].

• Authors : Di Fusco SA; U.O.C. Cardiologia Clinica e Riabilitativa, Presidio Ospedaliero San Filippo Neri, ASL Roma 1, Roma.; Di Michele S

Subjects: Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/drug therapy ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/prevention & control; Cholesterol, LDL

• Source: Giornale italiano di cardiologia (2006) [G Ital Cardiol (Rome)] 2021 Nov; Vol. 22 (11), pp. 922-931.Publisher: Il Pensiero Scientifico Editore Country of Publication: Italy NLM ID: 101263411 Publication Model: Print Cited Medium: Internet ISSN:

Record details